chrX-23783386-C-A

Variant summary

Our verdict is Benign. The variant received -9 ACMG points: 0P and 9B. BP4_StrongBP6BS2

The NM_002970.4(SAT1):​c.35C>A​(p.Ala12Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000458 in 1,209,544 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 158 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. A12T) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.00025 ( 0 hom., 8 hem., cov: 23)
Exomes 𝑓: 0.00048 ( 0 hom. 150 hem. )

Consequence

SAT1
NM_002970.4 missense

Scores

3
14

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:1

Conservation

PhyloP100: 0.396

Publications

2 publications found
Variant links:
Genes affected
SAT1 (HGNC:10540): (spermidine/spermine N1-acetyltransferase 1) The protein encoded by this gene belongs to the acetyltransferase family, and is a rate-limiting enzyme in the catabolic pathway of polyamine metabolism. It catalyzes the acetylation of spermidine and spermine, and is involved in the regulation of the intracellular concentration of polyamines and their transport out of cells. Defects in this gene are associated with keratosis follicularis spinulosa decalvans (KFSD). Alternatively spliced transcripts have been found for this gene.[provided by RefSeq, Sep 2009]
SAT1-DT (HGNC:56726): (SAT1 divergent transcript)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -9 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.037585407).
BP6
Variant X-23783386-C-A is Benign according to our data. Variant chrX-23783386-C-A is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 3157918.We mark this variant Likely_benign, oryginal submission is: [Conflicting_classifications_of_pathogenicity].
BS2
High Hemizygotes in GnomAd4 at 8 gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SAT1NM_002970.4 linkc.35C>A p.Ala12Asp missense_variant Exon 1 of 6 ENST00000379270.5 NP_002961.1 P21673A0A384NQ10
SAT1NR_027783.3 linkn.214C>A non_coding_transcript_exon_variant Exon 1 of 7
LOC127933115NM_001414725.1 linkc.*19C>A downstream_gene_variant NP_001401654.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SAT1ENST00000379270.5 linkc.35C>A p.Ala12Asp missense_variant Exon 1 of 6 1 NM_002970.4 ENSP00000368572.4 P21673
ENSG00000288706ENST00000683890.1 linkc.*19C>A downstream_gene_variant ENSP00000506989.1 A0A804HIB5

Frequencies

GnomAD3 genomes
AF:
0.000249
AC:
28
AN:
112232
Hom.:
0
Cov.:
23
show subpopulations
Gnomad AFR
AF:
0.0000970
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000377
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000376
Gnomad OTH
AF:
0.000657
GnomAD2 exomes
AF:
0.000280
AC:
51
AN:
182404
AF XY:
0.000224
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.000621
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000406
Gnomad OTH exome
AF:
0.000221
GnomAD4 exome
AF:
0.000479
AC:
526
AN:
1097260
Hom.:
0
Cov.:
29
AF XY:
0.000414
AC XY:
150
AN XY:
362632
show subpopulations
African (AFR)
AF:
0.0000758
AC:
2
AN:
26386
American (AMR)
AF:
0.000625
AC:
22
AN:
35186
Ashkenazi Jewish (ASJ)
AF:
0.0000516
AC:
1
AN:
19379
East Asian (EAS)
AF:
0.00
AC:
0
AN:
30200
South Asian (SAS)
AF:
0.00
AC:
0
AN:
54032
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
40518
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
4079
European-Non Finnish (NFE)
AF:
0.000584
AC:
491
AN:
841428
Other (OTH)
AF:
0.000217
AC:
10
AN:
46052
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.460
Heterozygous variant carriers
0
21
43
64
86
107
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000249
AC:
28
AN:
112284
Hom.:
0
Cov.:
23
AF XY:
0.000232
AC XY:
8
AN XY:
34468
show subpopulations
African (AFR)
AF:
0.0000968
AC:
3
AN:
30983
American (AMR)
AF:
0.000377
AC:
4
AN:
10619
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
2657
East Asian (EAS)
AF:
0.00
AC:
0
AN:
3535
South Asian (SAS)
AF:
0.00
AC:
0
AN:
2706
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
6165
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
218
European-Non Finnish (NFE)
AF:
0.000376
AC:
20
AN:
53182
Other (OTH)
AF:
0.000649
AC:
1
AN:
1540
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.515
Heterozygous variant carriers
0
1
3
4
6
7
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000254
Hom.:
2
Bravo
AF:
0.000412
ESP6500AA
AF:
0.00
AC:
0
ESP6500EA
AF:
0.000743
AC:
5
ExAC
AF:
0.000181
AC:
22
EpiCase
AF:
0.0000545
EpiControl
AF:
0.000475

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:1
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not specified Uncertain:1
Jan 19, 2025
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.35C>A (p.A12D) alteration is located in exon 1 (coding exon 1) of the SAT1 gene. This alteration results from a C to A substitution at nucleotide position 35, causing the alanine (A) at amino acid position 12 to be replaced by an aspartic acid (D). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

not provided Benign:1
Jun 01, 2024
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

SAT1: PP2, BS2 -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.11
BayesDel_addAF
Benign
-0.54
T
BayesDel_noAF
Benign
-0.67
CADD
Benign
17
DANN
Uncertain
0.98
DEOGEN2
Benign
0.010
T;T;.;T
FATHMM_MKL
Benign
0.45
N
LIST_S2
Benign
0.76
T;T;T;T
M_CAP
Uncertain
0.12
D
MetaRNN
Benign
0.038
T;T;T;T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
0.82
.;.;.;L
PhyloP100
0.40
PrimateAI
Uncertain
0.59
T
PROVEAN
Benign
0.86
N;N;N;N
REVEL
Benign
0.022
Sift
Benign
0.091
T;T;T;T
Sift4G
Benign
0.12
T;T;T;T
Polyphen
0.27, 0.0010
.;B;.;B
Vest4
0.17
MVP
0.33
MPC
1.5
ClinPred
0.020
T
GERP RS
1.1
PromoterAI
0.043
Neutral
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Varity_R
0.43
gMVP
0.70
Mutation Taster
=93/7
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs139915283; hg19: chrX-23801503; API